Table 3

Adverse events on TCZ

PatientAdverse eventTCZ outcomeDuration of TCZ suspension
Patient 1Varicella Zoster infectionRestarted6 weeks
Patient 3Chicken poxRestarted4 weeks
Patient 4Dental abscessRestarted8 weeks
Patient 5Myocardial infarctionRestarted2 weeks
Patient 6Severe allergic reactionDiscontinued–
Patient 8Leg ulcerOn Hold3 weeks
Patient 10Injection site reactionRestarted7 weeks
Patient 13Bladder cancerDiscontinued–
Patient 16Urinary tract infectionRestarted2 weeks

  • TCZ: tocilizumab.